U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226622) titled 'Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial' on Oct. 22.
Brief Summary: The aim of this study is to inform and improve future clinical trials in Wilson Disease (WD) by better understanding how patients with WD are living with and managing the disease, and by identifying key factors that shape their decisions to participate in clinical research.
Study Start Date: Dec., 2025
Study Type: OBSERVATIONAL
Condition:
Wilson Disease
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Prime Medicine, Inc.
Disclaimer: Curated by HT Syndication....